Back to CHARLES SCHWAB INVESTMENT MANAGEMENT INC CHARLES SCHWAB INVESTMENT MANAGEMENT INC

CLDXCLDX
Showing 8 of 24 quarters

Position history for CHARLES SCHWAB INVESTMENT MANAGEMENT INCCHARLES SCHWAB INVESTMENT MANAGEMENT INC's holdings in Celldex Therapeutics, Inc.

CHARLES SCHWAB INVESTMENT MANAGEMENT INC holds 655,954 shares of CLDX (Celldex Therapeutics, Inc.), worth $24.4M as of 2026-Q2. The position was increased (+20.3% shares). CLDX represents 0.0% of CHARLES SCHWAB INVESTMENT MANAGEMENT INC's portfolio.

Current Value

$24.4M

Current Shares

655,954

Total Value Change

+$6.1M

Total Shares Change

+117,098

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Increased
655,954
+20.3%
$24.4M0.0%$37.21
34
2026-Q1
Decreased
545,486
-0.9%
$17.3M0.0%$28.94
0
2025-Q4
Decreased
550,729
-0.6%
$15M0.0%$26.43
0
2025-Q3
Increased
553,873
+0.1%
$14.3M0.0%$26.19
28
2025-Q2
Increased
553,081
+3.2%
$11.3M0.0%$20.29
29
2025-Q1
Decreased
535,844
-1.6%
$9.7M0.0%$19.93
0
2024-Q4
Increased
544,330
+1.0%
$13.8M0.0%$25.12
28
2024-Q3
Increased
538,856
+1.6%
$18.3M0.0%$33.20
29

Other major holders of CLDX: BNP PARIBAS FINANCIAL MARKETS, WELLINGTON MANAGEMENT GROUP LLP

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used